Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Defamation Litigation Roundup: Jay-Z, Blake Lively, Drake No Photo Available

Theresa Schliep

In this month's review of ongoing defamation fights, Law360 looks back on an escalation in Jay-Z's case against personal injury lawyer... (more story)

Justices' Ruling Empowers FDA To Rein In Vapes, Experts Say No Photo Available

Sam Reisman

A unanimous U.S. Supreme Court decision affirming federal regulators' authority to deny marketing applications for flavored vapes was ... (more story)

5 Fed. Circ. Clashes To Watch This Month No Photo Available

Ryan Davis

The Federal Circuit will hear arguments this month in patent cases involving Moderna's COVID-19 vaccine and a blockbuster Johnson & Jo... (more story)